1,520 Alzheimers Headlines
Patricio Reyes M.D., F.A.N.N.
Director, Traumatic Brain Injury, Alzheimer's Disease & Cognitive Disorders Clinics; Phoenix, AZ; Chief Medical Officer, Retired NFL Players Association

Barrow Neurological Institute
St. Joseph's Hospital and Medical Center
"2 NEW THERAPIES FOR ALZHEIMER'S"
Produced by MD Health Channel
Executive Editor.....Anne-Merete Robbs
CEO..............Stan Swartz

Dr. Reyes and his team are constantly working on new medicines and new solutions...You will receive news alerts...information on new trials as Dr Reyes announces them!
"2 NEW THERAPIES FOR ALZHEIMER'S"
Patricio Reyes M.D., F.A.N.N.
Director, Traumatic Brain Injury, Alzheimer's Disease & Cognitive Disorders Clinics; Phoenix, AZ; Chief Medical Officer, Retired NFL Players Association

St. Joseph's Hospital and Medical Center



DO YOU HAVE ALZHEIMERS?
 
"HELP DR. REYES... IN HIS BATTLE TO FIND A CURE...
.HE NEEDS YOUR HELP:
YOU CAN HELP WIN THE BATTLE FOR A CURE BY JOINING A TRIAL!!"....

Stan Swartz, CEO,
The MD Health Channel



"You'll receive all medication and study based procedures at
no charge

if you qualify for one of the many trials being conducted at Barrow Neurological Institute."
 

"Dr. Reyes Changed My Life"

- John Swartz
92 Years Old
Attorney at Law
"Dr.Reyes Changed My Life "
1:18
"At 92...I had lost my will to live"
5:48
Tips on Aging
2:29
"Dr. Reyes gave me customized health care"
2:09

Patricio Reyes M.D.
Director, Traumatic Brain Injury, Alzheimer's Disease & Cognitive Disorders Clinics; Phoenix, AZ; Chief Medical Officer, Retired NFL Players Association

Barrow Neurological Institute

St. Joseph's Hospital and Medical Center
"PRESERVING BRAIN FUNCTIONS "
Runtime: 50:22
Runtime: 50:22
"2 NEW THERAPIES FOR ALZHEIMER'S"
Runtime: 10:27
Runtime: 10:27
ALZHEIMER'S AWARENESS PROGRAMS
Runtime: 5:00
Runtime: 5:00
BIOMEDICAL RESEARCH IN ALZHEIMER'S DISEASE
PDF Document 850 kb

Download Free

4 TALES OF NEUROSURGERY &
A PIANO CONCERT BY DR. SPETZLER...
Plus 2 books written by Survivors for Survivors!
Robert F. Spetzler M.D.
Director, Barrow Neurological Institute

J.N. Harber Chairman of Neurological Surgery

Professor Section of Neurosurgery
University of Arizona
TALES OF NEUROSURGERY:
A pregnant mother..a baby..faith of a husband.. .plus... Cardiac Standstill: cooling the patient to 15 degrees Centigrade!
Lou Grubb Anurism
The young Heros - kids who are confronted with significant medical problems!
2 Patients...confronted with enormous decisions before their surgery...wrote these books to help others!
A 1 MINUTE PIANO CONCERT BY DR. SPETZLER

Michele M. Grigaitis MS, NP
Alzheimer's Disease and Cognitive Disorders Clinic

Barrow Neurological Clinics
COPING WITH DEMENTIA
 
Free Windows Media Player Click

Links
Barrow Neurological Institute

Archives
October 2006  
November 2006  
December 2006  
January 2007  
February 2007  
March 2007  
May 2007  
June 2007  
November 2007  
December 2007  
April 2008  
July 2008  
August 2008  
September 2008  
October 2008  
November 2008  
December 2008  
January 2009  
February 2009  
March 2009  
April 2009  
May 2009  
February 2010  
March 2013  
May 2013  
November 2013  
January 2014  
February 2014  
March 2014  
April 2014  
May 2014  
June 2014  
July 2014  
June 2016  
July 2016  
August 2016  
September 2016  
October 2016  
November 2016  
December 2016  
January 2017  
February 2017  
March 2017  
April 2017  
May 2017  
June 2017  
July 2017  
August 2017  
September 2017  
October 2017  
November 2017  
December 2017  
January 2018  
February 2018  
March 2018  
April 2018  
May 2018  
June 2018  
July 2018  
August 2018  

This page is powered by Blogger. Isn't yours?

Saturday, April 1, 2017

 

VIRTUAL REALITY AIDS ALZHEIMER’S RESEARCH






















A new virtual-reality app modeled on a study on mice could help Alzheimer’s research, and University of Iowa professors and former researchers have been quick to recognize the app’s limits and applications.

Edmarie Guzman-Velez, a former UI doctoral student in clinical psychology and current postdoctoral fellow at Massachusetts General Hospital/Harvard, defined Alzheimer’s disease as a “progressive neurodegenerative disease that results in changes in cognition.”

“Usually, the first thing people start to notice is changes in their memory, but it eventually progresses to their motor and sensory cortexes, so the person has difficulty with movement and sensation,” she said.

Currently, all that is available for Alzheimer’s patients are drugs that can help slow down symptoms of the disease, not cure or prevent them, Guzman-Velez said.

Because of this, new technologies are continually explored to help the lives of those affected by the disease and to try to give patients “a few more years of independence and help them function normally, at least as much as possible,” she said.

One such technology is a new virtual reality app created by Samuel Sekandagu, a developer for virtual reality indie studio Overflow Games. The app was modeled after a study by Massachusetts Institute Technology’s Picower Institute for Learning and Memory.

Héctor De Jesús-Cortés, a former UI doctoral student of neuroscience and current postdoctoral fellow at the Picower Institute, was involved in the study that the app is based on.

The original study, Jesús-Cortés said, looked at mice that have a genetic mutation that predisposes them to have Alzheimer’s-like changes in the brain, resulting in a lower power in the frequency at which neurons fire.

“Neurons that are supposed to fire or communicate at a specific frequency were not communicating effectively,” he said. “The study thought to increase the frequency of gamma oscillation, the specific oscillations that were decreased.”

Andrew Pieper, a UI professor of psychiatry and neurology, said researchers used a technique called optogenetics to conduct the study.

In using optogenetics, the researchers “made these mice have light-responsive channels in their neuronal membranes so they could control when a neuron turns on or off by shining a light inside their brain,” Pieper said.

Using that technology, researchers activated neurons to fire at the specific gamma frequency, and this resulted in reduced pathology of Alzheimer’s disease, Jesús-Cortés said.

The application of the study is through the virtual-reality program because, he said, optogenetic cables can’t be inserted in humans. Like the study on mice, the program works by “stimulating the visual cortex of the brain by virtue of exposing the retina to lights at a certain frequency,” Pieper said.

“The idea is that with humans if you flash lights at a very specific frequency, you should be able to see a similar response in visual areas of the brain,” Guzman-Velez said.

While the app did reduce pathology of Alzheimer’s in specific areas of the brain, there are two major limitations to both it and the study itself. First, Pieper pointed out, the original study didn’t show behavior that would indicate if the reduced Alzheimer’s pathology also affects learning and memory deficits in the mice.

Additionally, the flickering lights of the virtual-reality app only affect the visual cortex, not such regions as the hippocampus, which affects learning and memory, Jesús-Cortés said.

“This is a very exciting topic, but the thing about virtual reality is that it needs more research at the basic level with mice to understand if it impacts behavior in other regions, like the hippocampus, to then be able to translate to humans,” Jesús-Cortés said. “If it works, it will be very exciting.”

While virtual reality may not be the most promising future for Alzheimer’s research, labs such as Pieper’s are making strides in other areas of neurodegeneration research, looking at new ways to treat neuropsychiatric diseases.

“It’s important to work on diseases that currently don’t have any effective treatments for patients,” Pieper said. “The opportunity to help people is enormous.”

Although Alzheimer’s poses especially difficult tasks for researchers, it’s important to not lose hope, Guzman-Velez said.

Story Source: The above story is based on materials provided by DAILY-IOWAN
Note: Materials may be edited for content and length